USD 1.2 billion
Report ID:
SQMIG35A2503 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
92
|Figures:
76
Spirometer Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.31 billion in 2024 to USD 2.69 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).
An increase in the number of chronic respiratory diseases, a change in preferences for home care and new technologies are expected to boost the growth of the market. WHO estimates that 90% of the global population breathe poor air quality that contains pollutants and irritants that impact lungs in several ways.
The spirometry equipment helps identify respiratory diseases such as obstructive chronic lung disease, emphysema, asthma and other lung diseases in an occupational environment. The rising incidence and prevalence rates of COPD in the global population also mean that the screening of COPD condition will be required, which will propel the need for spirometry tests. For instance, in November 2021, in the European Respiratory Journal, the authors pointed out that it is predicted that 49,453,852 Europeans will have COPD in 2050, while in 2020, it was 36,580,965. In addition, Netherlands also expected to have the highest incidence of COPD at 14.6%. Furthermore, research carried out in January 2021 and published in PLOS ONE found that in France, 2.6 million Chronic obstructive pulmonary disease affects people with a projection to reach 2.8 million by 2025. Hence, the continuously rising number of COPD patients will strengthen the need for technologically advanced spirometers, which will further boost the market growth.
Another factor is the increasing number of active ageing because they need the products offered by the markets most of the time. This demographic group is more vulnerable to chronic respiratory conditions and spirometry serves to diagnose them. Also, raising the popularity of enhanced diagnostic procedures among consumers is also promoting market growth. There are many new technologies which have facilitated the clinicians and hospitals to monitor patient data easily; this includes advancements in the design of spirometers which are now small and portable and can be connected to smart devices. Moreover, the development of new products with greater efficiency also boosts the research and development activities to drive the market.
Market snapshot - 2025-2032
Global Market Size
USD 1.2 billion
Largest Segment
Hand Held
Fastest Growth
Hand Held
Growth Rate
9.4% CAGR
To get more reports on the above market click here to Buy The Report
Global Spirometer Market is segmented by Product Type, Technology, Mechanism, Disease, Disposable Components, Application, End-User, Distribution Channel and region. Based on Product Type, the market is segmented into Software, Devices and Consumables and Accessories. Based on Technology, the market is segmented into Volume Measurement Spirometer, Flow Measurement Spirometer and Peak Flow Meter. Based on Mechanism, the market is segmented into Flow-Sensing Spirometer and Peak Flow Meters. Based on Disease, the market is segmented into Bronchitis, Emphysema, Chronic Obstructive Lung Disease, Lung Cancer and Others. Based on Disposable Components, the market is segmented into Filters, Sensors and Tubes. Based on Application, the market is segmented into Asthma, COPD, Cystic Fibrosis, Pulmonary Fibrosis and Others. Based on End-User, the market is segmented into Hospitals, Clinics and Homecare. Based on Distribution Channel, the market is segmented into Over the Counter and Direct Tender. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Analysis by Type
The handheld segment is the largest in the market, with USD 585.2 million in 2023, with a CAGR of 8.6% due to the increase in incidences of COPD and asthma, the increase in the global population of smokers, and the increased frequency of new product releases. For instance, in 2021, Cipla Limited launched Spirofy, a wireless spirometer that is portable and uses pneumotach technology, on World COPD Day. This launch is designed to COPD is diagnosed and is in tune with Cipla's strategy of strengthening its leadership position in the Indian respiratory market. In addition, in September 2023, Alveofit got approval for the Alveoair portable digital spirometer from the US FDA. It increases confidence in the transportability of spirometers and can lead to the evolution of respiratory diagnosis by making powerful, precise instruments available to clinicians and patients.
The tabletop is a growing segment in the market, which represents revenue of USD 451.1 million in 2023. Clinics and hospitals are the major users of tabletop spirometers, which are the costliest of all the types. This market segment is likely to expand at a faster rate because of its versatility in the treatment of respiratory disorders, including asthma, COPD, and other pulmonary disorders. Meanwhile, portable spirometers have been developed and preferred because of their light weight and small size, which enables them to store several diagnostic test results and print the results on normal printers.
The asthma segment holds the largest share in the market and is valued at USD 548. 42 million in 2023, with the CAGR expected to be at 8.8%. In 2022, CDC has estimated, around 8.7% of adults aged 18 and 6.2% of children under 18 years are affected by asthma in united states. Moreover, it is possible to find approximately 4.9 million office visits for asthma annually, with asthma documented in the medical record only in 6.3%. In addition, 939,000 patients visiting the emergency department have asthma as the main diagnosis excluding chronic obstructive asthma.
In 2023, the COPD segment is growing market share, driven by its widespread prevalence globally and the straightforward diagnosis via spirometry. COPD's prevalence is estimated at approximately 7.6% in europe. Spirometry is pivotal for both diagnosing and monitoring COPD. Nevertheless, the rise of mobile applications such as ResAppDx, capable of diagnosing COPD and exacerbations caused by infections, presents a potential alternative that could constrain segment expansion. Additionally, in 2022, the American Lung Association reported that 11.7 million individuals, representing 4.6% of adults, received a COPD diagnosis. Spirometry remains the cornerstone for diagnosing COPD, capable of detecting the condition even before symptoms appear. Healthcare providers rely on spirometry results to assess the severity of COPD and set treatment goals.
To get detailed analysis on other segments, Request For Free Sample Report
North America held the largest market share in 2023 with 38.04% due to increasing incidences of respiratory diseases. Asthma and COPD incidence has led to higher spirometer sales because of disease necessity and acceptance among hospital doctors. Also, the United States has been at the forefront of embracing technologies to reduce the incidences of COPD. Such factors indicate that the market has good potential for growth in the future for the given forecast period. Chronic respiratory diseases are prevalent in the United States, which increases the need to monitor the conditions through portable handheld spirometers.
The European market is growing at a higher rate during the forecast period owing to the rising number of product approvals from healthcare authorities. Government campaigns that seek to educate people on respiratory illnesses are also increasing the number of persons seeking diagnostic procedures. The well-developed hospital industry of Germany is also creating the need for sophisticated table-top spirometers for respiratory assessments. Spirometry devices used in hospitals, particularly those that are technologically advanced, are part of this market. Table-top spirometers give healthcare professionals the essential equipment to complete comprehensive respiratory evaluations and be able to diagnose different respiratory disorders. This increased demand for sophisticated spirometers is indicative of Germany's continuing focus on providing quality health care and developing new medical technologies.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Spirometer Market Drivers
Growing prevalence of respiratory diseases worldwide
Growing focus on public health initiatives and respiratory disease screening programs by governments
High cost of advanced spirometers, coupled with limited insurance reimbursement
Risks in spirometry testing impact patient confidence and healthcare provider
Request Free Customization of this report to help us to meet your business objectives.
The market is competitive and driven by technological factors and the expansion strategies implemented in the markets. Businesses are concerned with the improvement of spirometry tools to increase precision, ease of use, and patient tolerance. New entrants are gradually increasing their presence with niche products and partnerships. This category of strategies entails forming partnerships, mergers, and acquisitions to enhance market position and leverage the increasing demand for respiratory diagnostic solutions in the global market.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, the market is poised for significant growth, driven by several key factors. Rising prevalence of respiratory diseases globally, coupled with increasing awareness about the importance of respiratory health monitoring, is expanding the market demand. Technological advancements have led to a shift towards portable and user-friendly spirometers, catering to the growing trend of home healthcare solutions and remote patient monitoring. Integration of advanced monitoring capabilities, including real-time data access and analysis facilitated by technologies are enhancing the diagnostic precision of spirometry devices. However, the market faces challenges such as regulatory complexities, particularly in regions with stringent medical device regulations. Manufacturers must navigate these hurdles by ensuring compliance with quality standards and obtaining necessary certifications. Overall, with ongoing innovations and increasing adoption in healthcare settings worldwide, the Global Spirometer Market presents promising opportunities for growth and advancement in respiratory diagnostics.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 1.2 billion |
Market size value in 2032 | USD 2.69 billion |
Growth Rate | 9.4% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Spirometer Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Spirometer Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Spirometer Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Spirometer Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Spirometer Market size was valued at USD 1036.3 Million in 2023 and is poised to grow from USD 1124.59 Million in 2024 to USD 2158.57 Million by 2032, growing at a CAGR of 8.52% during the forecast period (2025-2032).
The market is competitive and driven by technological factors and the expansion strategies implemented in the markets. Businesses are concerned with the improvement of spirometry tools to increase precision, ease of use, and patient tolerance. New entrants are gradually increasing their presence with niche products and partnerships. This category of strategies entails forming partnerships, mergers, and acquisitions to enhance market position and leverage the increasing demand for respiratory diagnostic solutions in the global market. 'Baxter International Inc (US) ', 'Midmark Corporation (US) ', 'FutureMed (US) ', 'COSMED SRL (Italy) ', 'MGC Diagnostics Corporation (US) ', 'Medical International Research (MIR) (Italy) ', 'Vyaire Medical Inc (US) ', 'Vitalograph (UK) ', 'NDD Medical Technologies Inc (Switzerland) ', 'Schiller AG (Switzerland) ', 'Jones Medical Instrument Company (US) ', 'Sibelmed (Spain) ', 'Medline Industries LP (US) ', 'NCE Empowering Safety (US) ', 'Teleflex Inc (US) ', 'The Contec Group (China) ', 'Medikro (Finland) ', 'SDI Diagnostics (US) ', 'Chest M.I., Inc (Japan) ', 'Fukuda Sangyo Co. Ltd., (Japan)'
The spirometers are demanding for early detection, disease management, and treatment intervention for people with respiratory disorders. In 2020, the COPD incidence was estimated 10.6% in both males and females, equivalent to 480 million cases. The estimates of COPD prevalence suggest that the figure of COPD patients will increase by 112 million by 2050, totaling 592 million or 9.3% from year 2020 to year 2050. This rising is mainly due to the increasing prevalence of COPD among female patients and LMICs. In females, COPD is expected to rise to 7.8% in 2020 to 8.3% in 2050. The number of the population aged 65 and over was 8% in 2020 and 8.3% in 2050, a relative increase of 6.4%. The global prevalence of COPD in females is projected to rise from 177 million in the year 2020 to 260 million by the year 2050, this a rise of 83 million, 47.1% relative increase.
Advancements in spirometry technology: The development of new spirometry devices is now experiencing fast-growing demand in the global market due to better usability, portability, and cheaper prices. Some of the advancements include portable devices that have greatly enhanced respiratory care through enhanced portability and convenience of the devices to both the carers and the patients. These portable equipments allow pulmonary function tests in non-hospital environments, particularly in point-of-care and telemedicine settings. For instance, in January 2024, the Air Next spirometer developed by NuvoAir is a breakthrough, as it is the first spirometer approved by the FDA for home use. Moreover, incorporation with Smartphones has emerged as a trend that utilizes the existing popular devices to improve usability. spirometers are integrated with smartphone applications, which track patients’ respiratory health and share the data with their healthcare providers for assessment and management without physically visiting the clinic.
North America held the largest market share in 2023 with 38.04% due to increasing incidences of respiratory diseases. Asthma and COPD incidence has led to higher spirometer sales because of disease necessity and acceptance among hospital doctors. Also, the United States has been at the forefront of embracing technologies to reduce the incidences of COPD. Such factors indicate that the market has good potential for growth in the future for the given forecast period. Chronic respiratory diseases are prevalent in the United States, which increases the need to monitor the conditions through portable handheld spirometers.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2503
[email protected]
USA +1 351-333-4748